These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16950195)

  • 1. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
    Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
    Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life.
    Giglio V
    Am J Cardiol; 2007 Jan; 99(1):147-8. PubMed ID: 17196482
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy.
    Duboc D; Meune C; Lerebours G; Devaux JY; Vaksmann G; Bécane HM
    J Am Coll Cardiol; 2005 Mar; 45(6):855-7. PubMed ID: 15766818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of systolic dysfunction in duchenne muscular dystrophy due to the point mutation c.4213C>T.
    Finsterer J; Stöllberger C; Holinski-Feder E
    Cardiology; 2010; 117(4):265-7. PubMed ID: 21273767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition.
    Cardinale D; Colombo A; Sandri MT; Lamantia G; Colombo N; Civelli M; Martinelli G; Veglia F; Fiorentini C; Cipolla CM
    Circulation; 2006 Dec; 114(23):2474-81. PubMed ID: 17101852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
    Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
    Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy.
    Ogata H; Ishikawa Y; Ishikawa Y; Minami R
    J Cardiol; 2009 Feb; 53(1):72-8. PubMed ID: 19167641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did they lower stress in the trial? Or was it just wasted energy?
    Sanders SP
    J Am Coll Cardiol; 2005 Mar; 45(6):858-9. PubMed ID: 15766819
    [No Abstract]   [Full Text] [Related]  

  • 11. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up.
    Duboc D; Meune C; Pierre B; Wahbi K; Eymard B; Toutain A; Berard C; Vaksmann G; Weber S; Bécane HM
    Am Heart J; 2007 Sep; 154(3):596-602. PubMed ID: 17719312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac involvement in Fukuyama-type congenital muscular dystrophy.
    Nakanishi T; Sakauchi M; Kaneda Y; Tomimatsu H; Saito K; Nakazawa M; Osawa M
    Pediatrics; 2006 Jun; 117(6):e1187-92. PubMed ID: 16717122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the dual receptor endothelin antagonist enrasentan with enalapril in asymptomatic left ventricular systolic dysfunction: a cardiovascular magnetic resonance study.
    Prasad SK; Dargie HJ; Smith GC; Barlow MM; Grothues F; Groenning BA; Cleland JG; Pennell DJ
    Heart; 2006 Jun; 92(6):798-803. PubMed ID: 16339819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Female carrier of Duchenne muscular dystrophy presenting with secondary dilated cardiomyopathy: a case report].
    Hiramatsu S; Maekawa K; Hioka T; Takagaki K; Shoji K
    J Cardiol; 2001 Jul; 38(1):35-40. PubMed ID: 11496434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure.
    Aras D; Tufekcioglu O; Ergun K; Ozeke O; Yildiz A; Topaloglu S; Deveci B; Sahin O; Kisacik HL; Korkmaz S
    J Card Fail; 2006 Dec; 12(9):726-33. PubMed ID: 17174235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study.
    Mavrogeni S; Papavasiliou A; Douskou M; Kolovou G; Papadopoulou E; Cokkinos DV
    Eur J Paediatr Neurol; 2009 Jan; 13(1):34-40. PubMed ID: 18406648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
    Lipshultz SE; Lipsitz SR; Sallan SE; Simbre VC; Shaikh SL; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2002 Dec; 20(23):4517-22. PubMed ID: 12454107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy.
    Ogata H; Nakatani S; Ishikawa Y; Negishi A; Kobayashi M; Ishikawa Y; Minami R
    Int J Cardiol; 2007 Feb; 115(2):190-5. PubMed ID: 16843547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials.
    de Denus S; Tardif JC; White M; Bourassa MG; Racine N; Levesque S; Ducharme A
    Am Heart J; 2006 Oct; 152(4):705-12. PubMed ID: 16996842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
    Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
    Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.